```json
{
"content": [
{
"type": "paragraph",
"content": "Selected Reaction Monitoring (SRM), a mass spectrometry-based technique, enables precise quantification of proteins and peptides in complex biological samples, critical for advancing proteomics, clinical diagnostics, and biomarker discovery. As a cornerstone of targeted mass spectrometry, SRM’s selected reaction monitoring market size is witnessing rapid industry expansion, driven by its high specificity and sensitivity. The global SRM market, valued at USD 180 million in 2025, is projected to grow at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033, reflecting robust market forecast potential. Key macro drivers include escalating demand for personalized medicine, regulatory advancements in diagnostic validation, and technological innovations in tandem mass spectrometry."
},
{
"type": "list",
"title": "Key Forces Shaping the Selected Reaction Monitoring Market",
"items": [
{ "text": "R&D investments in proteomics and precision oncology are expanding SRM adoption in drug discovery and biomarker validation.", "level": 1 },
{ "text": "Integration with artificial intelligence (AI) for data analysis is enhancing SRM efficiency, reducing time-to-insight in clinical research.", "level": 1 },
{ "text": "Emerging markets in Asia-Pacific are accelerating adoption due to government-funded biotech initiatives and rising healthcare digitization.", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Currently, North America dominates the SRM market, accounting for over 45% of revenue in 2025, owing to its mature biopharmaceutical ecosystem and robust R&D infrastructure. However, the Asia-Pacific region is emerging as the fastest-growing market, with countries like India and China expanding their diagnostic capabilities and investing in next-generation sequencing technologies. Strategic partnerships between SRM equipment manufacturers and biotech firms, alongside decreasing assay costs, are expected to democratize access and fuel market expansion through 2033."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Instruments", "Reagents & Kits", "Software & Services"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145, 150], // Instruments
[40, 42, 45, 48, 50, 55, 60, 65, 70, 75, 80, 85, 90], // Reagents & Kits
[30, 33, 36, 39, 42, 45, 50, 55, 60, 65, 70, 75, 80] // Software & Services
]
}
}
]
}
```
